AMSL Diabetes are delighted to announce they have partnered with Tandem Diabetes Care®, Inc. to introduce their innovative product range to the Australian market for the very first time. The exclusive partnership is set to benefit Australian type 1 diabetes patients by offering them a new leading edge choice for their diabetes management.
Tandem Diabetes Care represents the latest addition to the AMSL Diabetes product range, which includes Dexcom Continuous Glucose Monitoring (CGM) systems, Lifescan OneTouch blood glucose meters, HypoPak Fast Acting Glucose and diabetes accessories.
About Tandem Diabetes Care, Inc.:
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialisation of products for people with diabetes who use insulin. Tandem is based in San Diego, California.
No date has been set for the official Australian launch of the Tandem Diabetes Care range however this is expected later in 2018 and will be subject to registration of the goods on the ARTG.
For more information about this announcement, please contact AMSL Diabetes on 1300 851 056 or email email@example.com.
Should you be interested in keeping up to date with future Tandem announcements, please complete our online form found here: